BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Estrogen Receptor-positive Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: BKM120|DRUG: Fulvestrant|PROCEDURE: biopsy
Sponsor: Washington University School of Medicine
Collaborators: National Cancer Institute (NCI)